6 Feb 2024 NBIX Neurocrine Biosciences, Inc. Matt Abernethy

Chief Financial Officer

Sale 2,260 $138.73 $313,530

6 Feb 2024

30,314 ↗ 31 Jan 2024 NBIX Neurocrine Biosciences, Inc. Matt Abernethy

Chief Financial Officer

Sale 1,283 $140.72 $180,544

31 Jan 2024

28,284 ↗ 21 Aug 2023 NBIX Neurocrine Biosciences, Inc. Matt Abernethy

Chief Financial Officer

Sale 2,132 $107.39 $228,955

21 Aug 2023

27,131 ↗ 6 Feb 2023 NBIX Neurocrine Biosciences, Inc. Matt Abernethy

Chief Financial Officer

Sale 28,588 $102.61 $2,933,415

6 Feb 2023

25,213 ↗ 31 Jan 2023 NBIX Neurocrine Biosciences, Inc. Matt Abernethy

Chief Financial Officer

Sale 1,283 $109.98 $141,104

31 Jan 2023

21,357 ↗ 7 Feb 2022 NBIX Neurocrine Biosciences, Inc. Matt Abernethy

Chief Financial Officer

Sale 4,290 $80.53 $345,474

7 Feb 2022

20,204 ↗ 1 Dec 2021 NBIX Neurocrine Biosciences, Inc. Matt Abernethy

Chief Financial Officer

Sale 1,645 $82.59 $135,861

1 Dec 2021

16,349 ↗ 8 Feb 2021 NBIX Neurocrine Biosciences, Inc. Matt Abernethy

Chief Financial Officer

Sale 2,910 $116.82 $339,946

8 Feb 2021

14,869 ↗ 1 Dec 2020 NBIX Neurocrine Biosciences, Inc. Matt Abernethy

Chief Financial Officer

Sale 1,645 $94.66 $155,716

1 Dec 2020

11,494 ↗ 5 Aug 2020 NBIX Neurocrine Biosciences, Inc. Matt Abernethy

Chief Financial Officer

Sale 2,257 $118.90 $268,357

5 Aug 2020

7,983 ↗ 7 May 2020 NBIX Neurocrine Biosciences, Inc. Matt Abernethy

Chief Financial Officer

Option 15,000 $73.60 $1,104,000

7 May 2020

20,953 ↗ 28 Apr 2020 NBIX Neurocrine Biosciences, Inc. Matt Abernethy

Chief Financial Officer

Sale 1,741 $102.49 $178,435

28 Apr 2020

5,953 ↗ 24 Apr 2020 NBIX Neurocrine Biosciences, Inc. Matt Abernethy

Chief Financial Officer

Sale 1,934 $99.52 $192,472

24 Apr 2020

7,694 ↗ 7 Feb 2020 NBIX Neurocrine Biosciences, Inc. Matt Abernethy

Chief Financial Officer

Sale 2,030 $103.35 $209,801

7 Feb 2020

5,701 ↗ 2 Dec 2019 NBIX Neurocrine Biosciences, Inc. Matt Abernethy

Chief Financial Officer

Sale 1,645 $116.33 $191,363

2 Dec 2019

3,876 ↗ 3 Dec 2018 NBIX Neurocrine Biosciences, Inc. Matt Abernethy

Chief Financial Officer

Sale 1,178 $90.00 $106,020

3 Dec 2018

1,947 ↗